Share: Facebook Twitter LinkedIn
Activity Provided By:

Clinical Care Options, LLC.

Expert Advice on Managing Severe Asthma

Access Activity

Overview / Abstract:

Target Audience

This activity is intended for allergists, immunologists, pulmonologists, primary care physicians, physician assistants, and other healthcare providers who care for patients with severe eosinophilic asthma.

Program Overview

The goal of this activity is to leverage a point-of-care tool along with expert commentary to improve the competence and performance of learners in diagnosing, assessing, and treating patients with severe eosinophilic asthma.

Learning Objectives

Upon completion of this activity, participants should be able to:

Select a biologic-based treatment strategy that targets the proinflammatory mechanisms of severe eosinophilic asthma
Describe the efficacy and safety of novel targeted biologic agents that have been recently approved as add-on therapy for severe eosinophilic asthma

Expiration

Aug 04, 2021

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.25 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty

Michael E. Wechsler, MD, MMSc
Michael E. Wechsler, MD, MMSc
Professor of Medicine
Director, NJH Cohen Family Asthma Institute
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Hospital
Denver, Colorado

Bradley E. Chipps, MDFAAP, FACAAI, FAAAAI, FCCP
Bradley E. Chipps, MDFAAP, FACAAI, FAAAAI, FCCP
President
Medical Director
Capital Allergy & Respiratory Disease Center
Sacramento, California

Nicola Alexander Hanania, MD, MS
Nicola Alexander Hanania, MD, MS
Associate Professor of Medicine
Department of Pulmonary and Critical Care Medicine
Baylor College of Medicine
Houston, Texas

Linda Rogers, MD
Linda Rogers, MD
Associate Professor of Medicine
Mount Sinai National Jewish Health Respiratory Institute
Icahn School of Medicine at Mount Sinai
Clinical Director, Adult Asthma Program
Division of Pulmonary, Critical Care, and Sleep Medicine
Department of Medicine
Mount Sinai Health System
New York, New York

Eileen Wang, MD, MPH
Eileen Wang, MD, MPH
Assistant Professor
Division of Allergy and Immunology
Department of Medicine
National Jewish Health
University of Colorado School of Medicine
Denver and Aurora, Colorado

Sponsors / Supporters / Grant Providers

Novartis Pharmaceuticals Corporation, Sanofi Genzyme, and Regeneron Pharmaceuticals.

Keywords / Search Terms

Relias LLC Relias LLC., FreeCME., Asthma Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map